GlassScriptPhysician profile
Todd S Koppel
NPI 1932109170
$4,104.45
in general payments reported to CMS, 2019-2025
30 companies · $876 in 2025
The $876 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $272 · 2021: $260 · 2022: $559 · 2023: $929 · 2024: $872 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,660 · Education: $17.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,660.04 |
| Education | $17.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,465.72 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $391.19 | 2020-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $344.26 | 2019-2025 | Xtampza |
| Spr Therapeutics, INC | $258.76 | 2024-2025 | Sprint Pns System |
| Arbor Pharmaceuticals, INC. | $195.01 | 2019-2022 | |
| Vertos Medical, INC. | $153.69 | 2023-2024 | Mild Device Kit |
| Kowa Pharmaceuticals America, INC. | $149.24 | 2022-2023 | Seglentis |
| Stryker Corporation | $145.83 | 2023 | Vitoss |
| Protega Pharmaceutials INC | $140.55 | 2023-2025 | Roxybond |
| Scilex Pharmaceuticals INC. | $128.89 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $100.39 | 2023-2025 | Horizant, Horizant |
| Si-Bone, INC. | $75.42 | 2022-2024 | |
| Masimo Corporation | $74.69 | 2024 | Set and Rainbow Set |
| Allergan, INC. | $67.63 | 2020-2022 | |
| Biodelivery Sciences International, INC. | $49.84 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $41.99 | 2019 | |
| Abbott Laboratories | $41.46 | 2019-2020 | |
| Almatica Pharma LLC | $39.43 | 2021 | |
| Daiichi Sankyo INC. | $35.20 | 2019 | |
| Valinor Pharma, LLC | $33.02 | 2025 | Movantik |
| Medtronic USA, INC. | $25.78 | 2020 | |
| Virtus Pharmaceuticals LLC | $24.75 | 2021 | |
| Boston Scientific Corporation | $18.11 | 2020 | |
| Curonix LLC | $17.96 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Avanos Medical | $15.68 | 2025 | Generator |
| Chiesi USA, INC. | $15.12 | 2023 | Cleviprex, Kengreal |
| Pacira Therapeutics, INC. | $14.87 | 2019 | |
| Abbvie INC. | $14.42 | 2022 | |
| Horizon Therapeutics Plc | $14.22 | 2022 | |
| Redhill Biopharma INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Koppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.